serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.322 Endocrine Gland Neoplasms .
C04.588.322.400 Multiple Endocrine Neoplasia .
C04.588.322.400.505 Multiple Endocrine Neoplasia Type 2a .
C04.651 Neoplasms, Multiple Primary .
C04.651.600 Multiple Endocrine Neoplasia .
C04.651.600.505 Multiple Endocrine Neoplasia Type 2a .
C04.700 Neoplastic Syndromes, Hereditary .
C04.700.630 Multiple Endocrine Neoplasia .
C04.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.700 Neoplastic Syndromes, Hereditary .
C16.320.700.630 Multiple Endocrine Neoplasia .
C16.320.700.630.505 Multiple Endocrine Neoplasia Type 2a .
C19 Endocrine System Diseases .
C19.344 Endocrine Gland Neoplasms .
C19.344.400 Multiple Endocrine Neoplasia .
C19.344.400.505 Multiple Endocrine Neoplasia Type 2a .
D02 Organic Chemicals .
D02.033 Alcohols .
D02.033.415 Fatty Alcohols .
D02.033.415.510 Hexanols .
D02.033.415.510.500 Cyclohexanols .
D02.033.415.510.500.303 Desvenlafaxine Succinate .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.392 Hydrocarbons, Alicyclic .
D02.455.426.392.368 Cycloparaffins .
D02.455.426.392.368.367 Cyclohexanes .
D02.455.426.392.368.367.318 Cyclohexanols .
D02.455.426.392.368.367.318.500 Desvenlafaxine Succinate .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.389 Benzene Derivatives .
D02.455.426.559.389.657 Phenols .
D02.455.426.559.389.657.265 Desvenlafaxine Succinate .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.725 Pyridines .
D03.383.725.762 Pyridinium Compounds .
D03.383.725.762.232 Cetylpyridinium .
D04 Polycyclic Compounds .
D04.345 Macrocyclic Compounds .
D04.345.566 Peptides, Cyclic .
D04.345.566.802 Streptogramins .
D04.345.566.802.374 Pristinamycin .
D04.345.566.802.500 Streptogramin Group A .
D04.345.566.802.500.500 Streptogramin A .
D04.345.566.802.750 Streptogramin Group B .
D04.345.566.802.750.500 Streptogramin B .
D04.345.566.802.875 Virginiamycin .
D04.345.566.802.875.500 Streptogramin A .
D10 Lipids .
D10.289 Fatty Alcohols .
D10.289.510 Hexanols .
D10.289.510.500 Cyclohexanols .
D10.289.510.500.303 Desvenlafaxine Succinate .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.641 Peptides, Cyclic .
D12.644.641.802 Streptogramins .
D12.644.641.802.374 Pristinamycin .
D12.644.641.802.500 Streptogramin Group A .
D12.644.641.802.500.500 Streptogramin A .
D12.644.641.802.750 Streptogramin Group B .
D12.644.641.802.750.500 Streptogramin B .
D12.644.641.802.875 Virginiamycin .
D12.644.641.802.875.500 Streptogramin A .
I01 Social Sciences .
I01.880 Sociology .
I01.880.604 Social Control, Formal .
I01.880.604.787 Prisons .
J03 Non-Medical Public and Private Facilities .
J03.693 Prisons .
VS3 Health Surveillance of Health Services .
VS3.002 Health Facilities .
VS3.002.010 Residential Facilities .
VS3.002.010.012 Prisons .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Streptogramin A .
Ostreogrycin G .
Pristinamycin IIA .
Pristinamycin IIB .
Staphylomycin M .
Staphylomycin M1 .
Virginiamycin IIB .
Virginiamycin M1 .
Virginiamycin Factor M1 .
A specific streptogramin group A antibiotic produced by Streptomyces graminofaciens and other bacteria. .
1.00
045
 
Pristinamycin .
Pyostacine .
RP 7293 .
RP7293 .
An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC. .
0.79
2101
 
Streptogramin B .
4-(4-(Dimethylamino)-N-methyl-L-phenylalanine)virginiamycin S1 .
Mikamycin B .
Osteogrycin B .
Pristinamycin IA .
Synergistin B .
Vernamycin Balpha .
A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria. .
0.70
0105
 
Desvenlafaxine Succinate .
2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate .
4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol .
Desvenlafaxine .
O-desmethylvenlafaxine .
O-desmethylvenlafaxine Succinate .
O-desmethylvenlafaxine Succinate Monohydrate .
Pristiq .
WY 45,233 .
WY 45233 .
WY-45,233 .
WY-45233 .
45,233, WY .
45233, WY .
Monohydrate, O-desmethylvenlafaxine Succinate .
O desmethylvenlafaxine .
O desmethylvenlafaxine Succinate .
O desmethylvenlafaxine Succinate Monohydrate .
Succinate Monohydrate, O-desmethylvenlafaxine .
Succinate, Desvenlafaxine .
Succinate, O-desmethylvenlafaxine .
WY45,233 .
WY45233 .
A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT. .
0.47
1248
 
Cetylpyridinium .
Angifonil .
Biosept .
Catamium .
Ceepryn Chloride .
Cetamium .
Cetylpyridinium Chloride .
Cetylpyridinium Chloride Anhydrous .
Cetylpyridium .
Cetylyre .
Dobendan .
Hexadecylpyridinium .
Merocets .
Pristacin .
Pyrisept .
Sterogenol .
Anhydrous, Cetylpyridinium Chloride .
Chloride Anhydrous, Cetylpyridinium .
Chloride, Ceepryn .
Chloride, Cetylpyridinium .
Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges. .
0.46
43859
 
Multiple Endocrine Neoplasia Type 2a .
MEA 2a .
MEA II .
MEA IIa .
MEN II .
MEN IIa .
MEN-2A Syndrome .
MEN2a .
Multiple Endocrine Neoplasia Type 2 .
Multiple Endocrine Neoplasia, Type IIa .
Multiple Endocrine Neoplasms Type 2a .
Pheochromocytoma And Amyloid-Producing Medullary Thyroid Carcinoma .
MEN 2A Syndrome .
MEN-2A Syndromes .
Pheochromocytoma And Amyloid Producing Medullary Thyroid Carcinoma .
MEN 2 .
MEN 2a .
Neoplasia, Multiple Endocrine Type 2a .
Neoplasms, Multiple Endocrine Type 2a .
Sipple Syndrome .
A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (CARCINOMA, MEDULLARY) of the THYROID GLAND, and usually with the co-occurrence of PHEOCHROMOCYTOMA, producing CALCITONIN and ADRENALINE, respectively. Less frequently, it can occur with hyperplasia or adenoma of the PARATHYROID GLANDS. This disease is due to gain-of-function mutations of the MEN2 gene on CHROMOSOME 10 (Locus: 10q11.2), also known as the RET proto-oncogene that encodes a RECEPTOR PROTEIN-TYROSINE KINASE. It is an autosomal dominant inherited disease. .
0.44
41191
 
Prisons .
Prison .
Social Adaptation Centers .
Penal Centers .
Jails .
Penal Institutions .
Reformatories .
Penal institutions, or places of confinement for prisoners. .
0.41
3988064